Document Type : Original Article

Authors

1 Department of Health Education and Health Promotion, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran

2 Department of Epidemiology and Biostatistics, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

BACKGROUND: Medication adherence means compliance with patient adherence to medication 
orders, including timely and correct consumption of medication prescribed by a physician. The present 
study aimed to determine the extent of adherence to hypertension drug medication in patients covered 
by comprehensive health service centers of Shahrekord, Iran.
MATERIALS AND METHODS: A cross‑sectional study examined 401 hypertensive patients 
registered in the Integrated Health Record System (SIB). SIB is a Persian term related to Health 
Record System. To collect data, Morisky Medication Adherence Scale was used. The questionnaire 
was completed by the patients and analyzed using SPSS (SPSS Inc., Chicago, Illinois, USA, 
version 26), Chi‑square test, independent t‑test, and analysis of variance.
RESULTS: The results indicated that adherence to antihypertensive medication was low in 5.7% of 
patients, while 63.3% of patients had sufficient compliance. Forgetting to take medications (52.9%) 
was the most common reason for nonadherence to medication in hypertensive patients.
CONCLUSION: Given that forgetting to take medications was the main reason for nonadherence 
to medication in hypertensive patients, designing and implementing necessary trainings by 
comprehensive health centers to realize the importance of daily use of medication by hypertensive 
patients and their families are recommended.

Keywords

1. Abu‑El‑Noor NI, Aljeesh YI, Bottcher B, Abu‑El‑Noor MK. 
Assessing barriers to and level of adherence to hypertension 
therapy among Palestinians living in the Gaza strip: A chance 
for policy innovation. Int J Hypertens 2020;2020:7650915.
2. Shrivastava SR, Shrivastava PS, Ramasamy J. The determinants 
and scope of public health interventions to tackle the global 
problem of hypertension. Int J Prev Med 2014;5:807‑12.
3. Arabshahi A, Gharlipour Z. Assessment of adherence to self‑care 
behaviors in hypertensive patients in Qom city (Iran).Qom Univ 
Med Sci J 2020;14:55‑65.
4. Boutayeb A, Boutayeb S. The burden of non communicable 
diseases in developing countries. Int J Equity Health 2005;4:2.
5. Ninomiya T, Ohara T, Hirakawa Y. Midlife and late‑life blood 
pressure and dementia in Japanese elderly. J Hisayama Study 
Hypertens2011;58:22‑8.
6. Wysocki M, Luo X, Schmeidler J, Dahlman K, Lesser GT, 
Grossman H, et al. Hypertension is associated with cognitive 
decline in elderly people at high risk for dementia. Am J Geriatr 
Psychiatry 2012;20:179‑87.
7. Tel H, Vei H. Anger and depression among the elderly people 
with hypertension. Neurol J Psychiatry Brain Res 2013;19:109‑13.
8. Heidenreich P, Trogdon J, Khavjou O, Butler J, Dracup K, 
Ezekowitz M, et al. Forecasting the future of cardiovascular 
disease in the United States: A policy statement from the American 
Heart Association. J Circulatio 2011;123:933‑4.
9. Oori MJ, Mohammadi F, Norozi K, Fallahi‑Khoshknab M, 
Ebadi A, GheshlaghRG. Prevalence of HTN in Iran: Meta‑analysis 
of Published Studies in 2004‑2018. Curr Hypertens Rev 
2019;15:113‑22.
10. De Geest S, Sabaté E. Adherence to long‑term therapies: Evidence 
for action. Eur J Cardiovasc Nurs 2003;2:323.
11. Ashoorkhani M, Bozorgi A, MajdzadehR, Hosseini H, Yoonessi A, 
Ramezankhani A, et al. Comparing the effectiveness of the 
BPMAP (blood pressure management application) and usual 
care in self‑management of primary hypertension and adherence 
to treatment in patients aged 30‑60 years: Study protocol for a 
randomized controlled trial. Trials 2016;17:511.
12. Rash JA, Lavoie KL, Feldman HR, Campbell TS. Adherence 
to antihypertensive medications: Current status and future 
directions. J Cur Cardio Risk Rep 2014;8:415‑18.
13. ALLHAT Officers and Coordinators for the ALLHAT 
Collaborative Research Group The Antihypertensive and 
Lipid‑Lowering Treatment to Prevent Heart Attack Trial. Major 
outcomes in high‑risk hypertensive patients randomized to 
angiotensin‑converting enzyme inhibitor or calcium channel 
blocker vs. diuretic: The antihypertensive and lipid‑lowering 
treatment to prevent heart attack trial (ALLHAT). JAMA 
2002;288:2981‑97.
14. Turnbull F, Neal B, Algert C, Chalmers J, Chapman N, Cutler J,
et al. Effects of different blood pressure‑lowering regimens on 
major cardiovascular events in individuals with and without 
diabetes mellitus: Results of prospectively designed overviews 
of randomized trials. Arch Intern Med 2005;165:1410‑9.
15. Burkhart P, Sabaté E. Adherence to long‑term therapies: Evidence 
for action. J Nurs Scholarsh 2003;35:207.
16. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The 
effects of initial drug choice and comorbidity on antihypertensive 
therapy compliance: Results from a population‑based study in 
the elderly. Am J Hypertens 1997;10:697‑704.
17. Jung O, GechterJL, Wunder C, Paulke A, Bartel C, Geiger H, et al.
Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens 2013;31:766‑74.
18. Matsumura K, Arima H, Tominaga M, Ohtsubo T, Sasaguri T, 
Fujii K, et al. Impact of antihypertensive medication adherence 
on blood pressure control in hypertension: The COMFORT study. 
QJM 2013;106:909‑14.
19. Lewington S, Clarke R, Qizilbash N, PetoR, Collins R; Prospective 
Studies Collaboration. Age‑specific relevance of usual blood 
pressure to vascular mortality: A meta‑analysis of individual 
data for one million adults in 61 prospective studies. Lancet 
2002;360:1903‑13.
20. Dragomir A, Côté R, Roy L, Blais L, Lalonde L, Bérard A, et al.
Impact of adherence to antihypertensive agents on clinical 
outcomes and hospitalization costs. Med Care 2010;48:418‑25.
21. Shin S, Song H, Oh SK, Choi KE, Kim H, Jang S. Effect of 
antihypertensive medication adherence on hospitalization for 
cardiovascular disease and mortality in hypertensive patients. 
Hypertens Res 2013;36:1000‑5.
22. Chowdhury R, Khan H, Heydon E, Shroufi A, Fahimi S, Moore C,
et al. Adherence to cardiovascular therapy: A meta‑analysis of 
prevalence and clinical consequences. Eur Heart J 2013;34:2940‑8.
23. Cutler DM, Long G, Berndt ER, Royer J, Fournier AA, Sasser A,
et al. The value of antihypertensive drugs: A perspective on 
medical innovation. Health Aff (Millwood) 2007;26:97‑110.
24. Morisky DE, Ang A, Krousel‑Wood M, Ward HJ. Predictive 
validity of a medication adherence measure in an outpatient 
setting. J Clin Hypertens (Greenwich) 2008;10:348‑54.
25. Koudhyar H, Shourvazi M, Dalir Z, Hosseini M. Survey of health 
literacy with adherence to treatment and quality among diabetes 
elders of community. Maz J Univ Mel Sci 2013;23:134‑43.
26. Paczkowska A, Hoffmann K. Impact of patient knowledge on 
hypertension treatment adherence and efficacy: A single –center 
study in Poland. Int J Med Sci 2021;18:852‑60.
27. Chunhua M. A cross-sectional survey of medication adherence 
and associated factors for rural patients with hypertension. Appl 
Nurs Res 2016;31:94‑9.
28. Kisokanth G, Ilankoon IM, Arulanandem K. Assesment of 
knowledge on the disease, its complications and management 
strategies among hypertensive patients attending medical clinics 
at teaching hospital, Batticaloa, Sri Lanka. JPGIM 2016;30:1‑11.
29. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient 
adherence and medical treatment outcomes: A meta‑analysis. 
Med Care 2002;40:794‑811.
30. Ezeala‑Adikaibe BA, Mbadiwe N, Okudo G. Factors associated 
with medication adherence among hypertensive patients in 
a tertiary health center: Across‑sectional study archives of 
community medicine. J Public Health 2017;3:24‑311.
31. Hosohata K, Inada A, Oyama S, Doi T, Niinomi I, Wakabayashi T,
et al. Improvement of blood pressure control by adherence check in 
patients with apparent treatment‑Resistant hypertension: A case 
series. Clin Med Insights Case Rep 2020;13:1179547620904884.
32. Sawicka K, Szczepanska J. Evaluation of the level of knowledge 
of patients with hypertensive disease in prevention and 
complications of hypertension. J Educ Health Sport 2016;6:296‑321.
33. AkokoBM, FonPN, NguRC, Ngu KB. Knowledge of hypertension 
and compliance with therapy among hypertensive patients in the 
Bamenda health district of Cameroon: A Cross‑sectional study. 
Cardiol Ther 2017;6:53‑67.
34. Al‑Ramahi R. Adherence to medications and associated factors: 
A cross‑sectional study among Palestinian hypertensive patients. 
J Epidemiol Glob Health 2015;5:125‑32.
35. Brent BM, Zhao Y, Axon RN. US trends in prevalence, awareness, 
treatment, and control of hypertension, 1988‑2008. JAMA 
2010;303:2043‑50.
36. Shani M, Lustman A, Vinker S. Adherence to oral 
antihypertensive medications, are all medications equal? J Clin 
Hypertens (Greenwich) 2019;21:243‑8.
37. Haynes RB, Montague P, Oliver T, McKibbon KA, Brouwers MC, 
KananiR. Interventions for helping patients to follow prescriptions 
for medications. J Cochrane Database Syst Rev. 2005; 19:CD000011.
38. Dimatto MR. Variations in patients adherence to medival 
recommendations: A quantitative review of 50 years of research. 
J Med Care 2004;42:200‑9.
39. Cheong W, Yim J. The effect of a clinic based incentive program 
on medication adherence among patients with hypertension 
or diabetes mellitus in Incheon. J Health Policy Manage 
2013;23:427‑33.
40. Sun Z, Zheng L, Detrano R, Zhang X, Xu C, Li J, et al. Risk of 
progression to hypertension in a rural Chinese women population 
with prehypertension and normal blood pressure. Am J Hypertens 
2010;23:627‑32.